Report Detail
Global Bioresorbable Scaffolds Market Report 2018-2029
- RnM3088349 |
- 22 August, 2023 |
- Global |
- 145 Pages |
- HJResearch |
- Other
Bioresorbable Scaffolds are devices that are used in the treatment of coronary artery disease (CAD) and peripheral arterial disease (PAD). They are designed to provide temporary support for a blood vessel, while allowing it to heal and remodel naturally over time. These scaffolds are typically made of biodegradable materials such as polymers or magnesium alloys, which are gradually absorbed into the body after implantation.
Bioresorbable Scaffolds are used in a range of vascular interventions, including coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), and treatments for PAD. They are intended to offer several benefits over traditional metallic stents, including reduced risk of future blockages, improved long-term outcomes, and greater patient comfort.
As for the industry status, the global Bioresorbable Scaffolds market is experiencing significant growth, with a projected market size of US$239.71 million in 2022 and a compound annual growth rate (CAGR) of 24.86%. This growth is driven by the increasing prevalence of CAD and PAD, rising demand for minimally invasive procedures, and the adoption of advanced technologies in cardiac care.
The major global manufacturers in this industry include Abbott Laboratories, Amaranth Medical, Arterial Remodeling Technologies, BIOTRONIK, Elixir Medical, Kyoto Medical Planning, and Xenogenics Corporation. These companies offer a range of Bioresorbable Scaffolds, such as Absorb GT1 Bioresorbable Vascular Scaffold System by Abbott Laboratories, MAGNITUDE Bioresorbable Scaffold by Amaranth Medical.
Looking forward, the prospects of the Bioresorbable Scaffolds industry are promising, given the increasing prevalence of CAD and PAD. The ongoing research and development activities in this field are expected to lead to the development of new and improved Bioresorbable Scaffolds that will enhance the efficiency, safety, and effectiveness of vascular interventions. Additionally, the emergence of technologies such as Artificial Intelligence (AI) and Internet of Things (IoT) is expected to further drive the growth of this industry by enabling smarter, more efficient, and data-driven interventions.
In conclusion, the Bioresorbable Scaffolds industry plays a crucial role in the treatment of CAD and PAD. It is experiencing significant growth, with a projected market size of US$239.71 million in 2022. With the increasing prevalence of CAD and PAD and the adoption of advanced technologies, the prospects of this industry are promising, and it is expected to continue growing in the coming years.
The SWOT analysis of the Bioresorbable Scaffolds industry is as follows:
Strengths:
Bioresorbable Scaffolds offer several benefits over traditional metallic stents, including reduced risk of future blockages and improved long-term outcomes.
Increasing prevalence of coronary artery disease (CAD) and peripheral arterial disease (PAD) is driving the demand for Bioresorbable Scaffolds.
Advances in research and development are leading to the development of new and improved Bioresorbable Scaffolds that enhance the efficiency, safety, and effectiveness of vascular interventions.
Strong presence of major global manufacturers with established brands and reputation.
Weaknesses:
Biodegradable materials used in Bioresorbable Scaffolds may not be as durable as metallic stents, leading to potential complications such as scaffold thrombosis and stent fracture.
High cost associated with the development and manufacturing of Bioresorbable Scaffolds, leading to limited affordability and accessibility for small-scale players.
Complexity and sophistication of the technology, leading to a shortage of skilled personnel and the need for ongoing training and development.
Opportunities:
Increasing demand for minimally invasive procedures, leading to greater adoption of Bioresorbable Scaffolds.
Emergence of technologies such as Artificial Intelligence (AI) and Internet of Things (IoT), leading to smarter, more efficient, and data-driven interventions.
Growing market potential in developing countries with increasing prevalence of CAD and PAD.
Threats:
Intense competition from existing and new players, leading to price wars and reduced profit margins.
Regulatory hurdles and compliance requirements, leading to higher costs and delays in obtaining approvals.
Potential risks associated with the use of Bioresorbable Scaffolds, such as scaffold thrombosis, stent fracture and other complications.
Key players in global Bioresorbable Scaffolds market include:
Abbott Laboratories
Amaranth Medical
Arterial Remodeling Technologies
BIOTRONIK
Elixir Medical
Kyoto Medical Planning
Xenogenics Corporation
Market segmentation, by product types:
Metallic Bioresorbable Scaffolds
Polymer Bioresorbable Scaffolds
Market segmentation, by applications:
Coronary Artery Disease
Coronary Artery Bypass Grafting (CABG)
Peripheral Arterial Disease
1 Industry Overview of Bioresorbable Scaffolds
- 1.1 Research Scope
- 1.2 Market Segmentation by Types of Bioresorbable Scaffolds
- 1.3 Market Segmentation by End Users of Bioresorbable Scaffolds
- 1.4 Market Dynamics Analysis of Bioresorbable Scaffolds
- 1.4.1 Market Drivers
- 1.4.2 Market Challenges
- 1.4.3 Market Opportunities
- 1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Bioresorbable Scaffolds Industry
- 2.1 Abbott Laboratories
- 2.1.1 Company Overview
- 2.1.2 Main Products and Specifications
- 2.1.3 Bioresorbable Scaffolds Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.1.4 Contact Information
- 2.2 Amaranth Medical
- 2.2.1 Company Overview
- 2.2.2 Main Products and Specifications
- 2.2.3 Bioresorbable Scaffolds Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.2.4 Contact Information
- 2.3 Arterial Remodeling Technologies
- 2.3.1 Company Overview
- 2.3.2 Main Products and Specifications
- 2.3.3 Bioresorbable Scaffolds Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.3.4 Contact Information
- 2.4 BIOTRONIK
- 2.4.1 Company Overview
- 2.4.2 Main Products and Specifications
- 2.4.3 Bioresorbable Scaffolds Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.4.4 Contact Information
- 2.5 Elixir Medical
- 2.5.1 Company Overview
- 2.5.2 Main Products and Specifications
- 2.5.3 Bioresorbable Scaffolds Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.5.4 Contact Information
- 2.6 Kyoto Medical Planning
- 2.6.1 Company Overview
- 2.6.2 Main Products and Specifications
- 2.6.3 Bioresorbable Scaffolds Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.6.4 Contact Information
- 2.7 Xenogenics Corporation
- 2.7.1 Company Overview
- 2.7.2 Main Products and Specifications
- 2.7.3 Bioresorbable Scaffolds Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.7.4 Contact Information
3 Global Bioresorbable Scaffolds Market Analysis by Regions, Manufacturers, Types and End Users
- 3.1 Global Sales Volume and Revenue of Bioresorbable Scaffolds by Regions (2018-2023)
- 3.2 Global Sales Volume and Revenue of Bioresorbable Scaffolds by Manufacturers (2018-2023)
- 3.3 Global Sales Volume and Revenue of Bioresorbable Scaffolds by Types (2018-2023)
- 3.4 Global Sales Volume and Revenue of Bioresorbable Scaffolds by End Users (2018-2023)
- 3.5 Selling Price Analysis of Bioresorbable Scaffolds by Regions, Manufacturers, Types and End Users in (2018-2023)
4 Northern America Bioresorbable Scaffolds Market Analysis by Countries, Types and End Users
- 4.1 Northern America Bioresorbable Scaffolds Sales Volume and Revenue Analysis by Countries (2018-2023)
- 4.2 Northern America Bioresorbable Scaffolds Sales Volume and Revenue Analysis by Types (2018-2023)
- 4.3 Northern America Bioresorbable Scaffolds Sales Volume and Revenue Analysis by End Users (2018-2023)
- 4.4 United States Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 4.5 Canada Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5 Europe Bioresorbable Scaffolds Market Analysis by Countries, Types and End Users
- 5.1 Europe Bioresorbable Scaffolds Sales Volume and Revenue Analysis by Countries (2018-2023)
- 5.2 Europe Bioresorbable Scaffolds Sales Volume and Revenue Analysis by Types (2018-2023)
- 5.3 Europe Bioresorbable Scaffolds Sales Volume and Revenue Analysis by End Users (2018-2023)
- 5.4 Germany Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.5 France Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.6 UK Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.7 Italy Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.8 Russia Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.9 Spain Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.10 Netherlands Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6 Asia Pacific Bioresorbable Scaffolds Market Analysis by Countries, Types and End Users
- 6.1 Asia Pacific Bioresorbable Scaffolds Sales Volume and Revenue Analysis by Countries (2018-2023)
- 6.2 Asia Pacific Bioresorbable Scaffolds Sales Volume and Revenue Analysis by Types (2018-2023)
- 6.3 Asia Pacific Bioresorbable Scaffolds Sales Volume and Revenue Analysis by End Users (2018-2023)
- 6.4 China Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.5 Japan Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.6 Korea Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.7 India Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.8 Australia Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.9 Indonesia Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.10 Vietnam Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7 Latin America Bioresorbable Scaffolds Market Analysis by Countries, Types and End Users
- 7.1 Latin America Bioresorbable Scaffolds Sales Volume and Revenue Analysis by Countries (2018-2023)
- 7.2 Latin America Bioresorbable Scaffolds Sales Volume and Revenue Analysis by Types (2018-2023)
- 7.3 Latin America Bioresorbable Scaffolds Sales Volume and Revenue Analysis by End Users (2018-2023)
- 7.4 Brazil Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.5 Mexico Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.6 Argentina Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.7 Colombia Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8 Middle East & Africa Bioresorbable Scaffolds Market Analysis by Countries, Types and End Users
- 8.1 Middle East & Africa Bioresorbable Scaffolds Sales Volume and Revenue Analysis by Countries (2018-2023)
- 8.2 Middle East & Africa Bioresorbable Scaffolds Sales Volume and Revenue Analysis by Types (2018-2023)
- 8.3 Middle East & Africa Bioresorbable Scaffolds Sales Volume and Revenue Analysis by End Users (2018-2023)
- 8.4 Turkey Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.5 Saudi Arabia Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.6 South Africa Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.7 Egypt Bioresorbable Scaffolds Sales Volume, Revenue, Import and Export Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
- 9.1 Marketing Channel
- 9.1.1 Direct Channel
- 9.1.2 Indirect Channel
- 9.2 Distributors and Traders
10 Global Bioresorbable Scaffolds Market Forecast by Regions, Countries, Manufacturers, Types and End Users
- 10.1 Global Sales Volume and Revenue Forecast of Bioresorbable Scaffolds by Regions (2024-2029)
- 10.2 Global Sales Volume and Revenue Forecast of Bioresorbable Scaffolds by Types (2024-2029)
- 10.3 Global Sales Volume and Revenue Forecast of Bioresorbable Scaffolds by End Users (2024-2029)
- 10.4 Global Revenue Forecast of Bioresorbable Scaffolds by Countries (2024-2029)
- 10.4.1 United States Revenue Forecast (2024-2029)
- 10.4.2 Canada Revenue Forecast (2024-2029)
- 10.4.3 Germany Revenue Forecast (2024-2029)
- 10.4.4 France Revenue Forecast (2024-2029)
- 10.4.5 UK Revenue Forecast (2024-2029)
- 10.4.6 Italy Revenue Forecast (2024-2029)
- 10.4.7 Russia Revenue Forecast (2024-2029)
- 10.4.8 Spain Revenue Forecast (2024-2029)
- 10.4.9 Netherlands Revenue Forecast (2024-2029)
- 10.4.10 China Revenue Forecast (2024-2029)
- 10.4.11 Japan Revenue Forecast (2024-2029)
- 10.4.12 Korea Revenue Forecast (2024-2029)
- 10.4.13 India Revenue Forecast (2024-2029)
- 10.4.14 Australia Revenue Forecast (2024-2029)
- 10.4.15 Indonesia Revenue Forecast (2024-2029)
- 10.4.16 Vietnam Revenue Forecast (2024-2029)
- 10.4.17 Brazil Revenue Forecast (2024-2029)
- 10.4.18 Mexico Revenue Forecast (2024-2029)
- 10.4.19 Argentina Revenue Forecast (2024-2029)
- 10.4.20 Colombia Revenue Forecast (2024-2029)
- 10.4.21 Turkey Revenue Forecast (2024-2029)
- 10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
- 10.4.23 South Africa Revenue Forecast (2024-2029)
- 10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Bioresorbable Scaffolds
- 11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Bioresorbable Scaffolds
- 11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Bioresorbable Scaffolds
- 11.1.2 Major Equipment Suppliers with Contact Information Analysis of Bioresorbable Scaffolds
- 11.2 Downstream Major Consumers Analysis of Bioresorbable Scaffolds
- 11.3 Major Suppliers of Bioresorbable Scaffolds with Contact Information
- 11.4 Supply Chain Relationship Analysis of Bioresorbable Scaffolds
12 Bioresorbable Scaffolds New Project Investment Feasibility Analysis
- 12.1 Bioresorbable Scaffolds New Project SWOT Analysis
- 12.2 Bioresorbable Scaffolds New Project Investment Feasibility Analysis
- 12.2.1 Project Name
- 12.2.2 Investment Budget
- 12.2.3 Project Product Solutions
- 12.2.4 Project Schedule
13 Bioresorbable Scaffolds Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.2 References and Data Sources
- 14.2.1 Primary Sources
- 14.2.2 Secondary Paid Sources
- 14.2.3 Secondary Public Sources
- 14.3 Abbreviations and Units of Measurement
- 14.4 Author Details
Summary:
Get latest Market Research Reports on Bioresorbable Scaffolds. Industry analysis & Market Report on Bioresorbable Scaffolds is a syndicated market report, published as Global Bioresorbable Scaffolds Market Report 2018-2029. It is complete Research Study and Industry Analysis of Bioresorbable Scaffolds market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
